Erydel
Encapsulating Drug Treatments in Patient's Red Blood Cells
2
Funding Rounds
$35.5m
Money raised
Overview
Encapsulating Drug Treatments in Patient's Red Blood Cells
- Website:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Erydel has raised a total of $35.45m in funding over 2 rounds.
Key Insights:
- Erydel , April 2018: $32.3m
- Erydel Series A round: $3.15m
Erydel , April 2018
$32.3m
Erydel Series A round
$3.15m
Industries
Erydel is active in the following industries: